0528 FTC rebates
BioCentury & Getty Images

Politics, Policy & Law

FTC signals interest in freeing biosimilars and drugs from ‘rebate traps’

May 28, 2021 | 7:06 PM GMT

The Federal Trade Commission Friday signaled its intention to prevent pharmaceutical companies from using rebates to inhibit competition from lower-priced drugs, especially biosimilars.

In a

Read the full 512 word article

How to gain access

Continue reading with a
two-week free trial.